Short Interest in NeueHealth, Inc. (NYSE:NEUE) Declines By 65.9%

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 10,000 shares, a decrease of 65.9% from the March 31st total of 29,300 shares. Currently, 0.4% of the shares of the stock are short sold. Based on an average daily volume of 24,700 shares, the short-interest ratio is presently 0.4 days.

NeueHealth Trading Down 0.6 %

Shares of NYSE:NEUE traded down $0.04 during trading on Thursday, reaching $6.84. The company's stock had a trading volume of 5,756 shares, compared to its average volume of 20,396. The firm's 50 day simple moving average is $6.54 and its two-hundred day simple moving average is $6.27. NeueHealth has a 12 month low of $3.79 and a 12 month high of $7.66. The stock has a market capitalization of $56.67 million, a PE ratio of -0.13 and a beta of 0.54.

NeueHealth (NYSE:NEUE - Get Free Report) last released its earnings results on Thursday, March 20th. The company reported ($7.41) earnings per share for the quarter, missing the consensus estimate of ($2.29) by ($5.12). The company had revenue of $232.64 million for the quarter, compared to the consensus estimate of $261.80 million. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. Research analysts anticipate that NeueHealth will post -9.13 EPS for the current fiscal year.

Insider Transactions at NeueHealth

In related news, CFO Jay Matushak sold 4,448 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total transaction of $29,979.52. Following the completion of the transaction, the chief financial officer now directly owns 41,592 shares of the company's stock, valued at approximately $280,330.08. This represents a 9.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO George Lawrence Mikan III sold 13,180 shares of NeueHealth stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total value of $91,337.40. Following the completion of the sale, the chief executive officer now directly owns 297,790 shares in the company, valued at approximately $2,063,684.70. The trade was a 4.24 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 68,178 shares of company stock valued at $467,763 over the last three months. Corporate insiders own 64.30% of the company's stock.

Hedge Funds Weigh In On NeueHealth

An institutional investor recently raised its position in NeueHealth stock. Northern Trust Corp lifted its holdings in NeueHealth, Inc. (NYSE:NEUE - Free Report) by 66.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 32,644 shares of the company's stock after buying an additional 13,074 shares during the quarter. Northern Trust Corp owned approximately 0.39% of NeueHealth worth $242,000 at the end of the most recent quarter. Institutional investors and hedge funds own 63.88% of the company's stock.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.